Author: Rob Visor

Combining melatonin with sedatives can cause dangerous additive drowsiness, impaired breathing, and next-day impairment. Learn the risks, safety tips, and safer alternatives for better sleep without the danger.

Lithium carbonate generics require careful serum level monitoring due to narrow therapeutic ranges and formulation differences. Even bioequivalent generics can affect blood levels differently, risking toxicity or reduced efficacy in bipolar disorder treatment.

Generic and brand-name drugs contain the same active ingredient, so their risk for drug interactions is identical. Regulatory standards ensure bioequivalence, and real-world data confirms no higher risk with generics.

Carpal tunnel syndrome is a common nerve compression disorder causing numbness, pain, and weakness in the hand. Learn how it develops, how to diagnose it early, and what treatments actually work-from splints to surgery.

Decision aids help patients understand the real risks and benefits of switching medications, especially when side effects are a concern. They use clear visuals, personal values, and evidence to guide shared decisions with providers.

Studies show that switching to generic versions of narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and cyclosporine can lead to dangerous fluctuations in blood levels. While some patients remain stable, others face seizures, organ rejection, or bleeding. Monitoring is critical after any switch.

Corrective actions help manufacturers find the real reason behind quality problems and stop them from happening again. Learn the 6-step process, common mistakes, and how to build a system that works.

Insurers use preferred generic lists to cut drug costs and lower premiums. These formularies steer patients toward cheaper, equally effective generics - saving billions annually. Learn how they work, where they fall short, and how to navigate them.

Orthostatic hypotension is a dangerous side effect of blood pressure meds in older adults. Learn which drugs raise fall risk, which are safest, and how to prevent dizziness without stopping treatment.

The FDA is cracking down on manufacturing defects in pharma and medical devices, with aseptic failures, data falsification, and poor material controls leading to widespread warning letters in 2025. Learn the top issues and how to fix them.